Treatment of Advanced Non-Small Cell Lung Cancer: PVp Versus PVpM Versus PVe Versus PVeMI Versus FOMi/CAP

Racial disparities in survival of patients with sex-specific cancers treated on Southwest Oncology Group clinical trials. PMC2724852; PMID: 19584328

KS Albain;JM Unger;JJ Crowley;CA Coltman;DL Hershman Journal of the National Cancer Institute 101(14):984-992

Minority report: how best to analyze clinical trial data to address disparities

D Hershman;J Unger Breast Cancer Research and Treatment 118:519-521

A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: A Southwest Oncology Group study.

JK Weick;J Crowley;RB Natale;BL Hom;S Rivkin;CA Coltman Jr;SA Taylor;RB Livingston Classic Papers and Current Comments (2)1:172-177

Current management of unresectable non-small cell lung cancer

RB Livingston Seminars in Oncology 21(5)(Suppl.10):4-12

A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: A Southwest Oncology Group study.

JK Weick;J Crowley;RB Natale;BL Hom;S Rivkin;CA Coltman, Jr;SA Taylor;RB Livingston JCO 9(7):1157-1162

Treatment for advanced non-small cell lung cancer (NSCLC):platinum and VP-16 (PVp) +MGBG (PVpM) vs. platinum and vinblastine(PVe) +mitomycin-C (PVeMI) vs. 5-FU + vincristine +mitomycin-C/cyclophosphamide + doxorubicin + platinum(FOMi/CAP).

J Weick;R Natale;J Crowley;B Hom;R Livingston ASCO 5:177(#692)